CHAMPIONS ONCOLOGY, INC. Operating Lease, Liability, Noncurrent
CHAMPIONS ONCOLOGY, INC. (CSBR) had Operating Lease, Liability, Noncurrent of $9.89 million as of 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-09-11
- 2026-07-31: Operating Lease, Liability, Noncurrent $9.89M.
- 2026-04-30: Operating Lease, Liability, Noncurrent $2.99M.
- 2026-01-31: Operating Lease, Liability, Noncurrent $3.37M.
- 2025-10-31: Operating Lease, Liability, Noncurrent $3.74M.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-07-31 | $9.89M 10-Q · filed 2026-09-11 | |
| 2026-04-30 | $2.99M 10-Q · filed 2026-09-11 | |
| 2026-01-31 | $3.37M 10-Q · filed 2026-03-12 | |
| 2025-10-31 | $3.74M 10-Q · filed 2025-12-15 | |
| 2025-07-31 | $4.24M 10-Q · filed 2025-09-15 | |
| 2025-04-30 | $4.63M 10-K · filed 2026-07-27 | |
| 2025-01-31 | $5.00M 10-Q · filed 2025-03-17 | |
| 2024-10-31 | $5.37M 10-Q · filed 2024-12-16 | |
| 2024-07-31 | $5.74M 10-Q · filed 2024-09-13 | |
| 2024-04-30 | $6.09M 10-K · filed 2025-07-23 | |
| 2024-01-31 | $6.44M 10-Q · filed 2024-03-15 | |
| 2023-10-31 | $6.78M 10-Q · filed 2023-12-13 | |
| 2023-07-31 | $7.11M 10-Q · filed 2023-09-13 | |
| 2023-04-30 | $7.39M 10-K · filed 2024-07-19 | |
| 2023-01-31 | $7.70M 10-Q · filed 2023-03-16 | |
| 2022-10-31 | $7.83M 10-Q · filed 2022-12-13 | |
| 2022-07-31 | $8.13M 10-Q · filed 2022-09-12 | |
| 2022-04-30 | $8.41M 10-K · filed 2023-07-24 | |
| 2022-01-31 | $8.62M 10-Q · filed 2022-03-15 | |
| 2021-10-31 | $8.53M 10-Q · filed 2021-12-13 | |
| 2021-07-31 | $8.65M 10-Q · filed 2021-09-13 | |
| 2021-04-30 | $8.78M 10-K · filed 2022-07-22 | |
| 2021-01-31 | $5.80M 10-Q · filed 2021-03-15 | |
| 2020-10-31 | $5.93M 10-Q · filed 2020-12-14 | |
| 2020-07-31 | $6.04M 10-Q · filed 2020-09-14 | |
| 2020-05-01 | $8.78M 10-K · filed 2022-07-22 | $3.17M 10-K · filed 2021-07-26 |
| 2020-04-30 | $3.17M 10-K · filed 2021-07-26 | |
| 2020-01-31 | $3.30M 10-Q · filed 2020-03-16 | |
| 2019-10-31 | $3.43M 10-Q · filed 2019-12-16 | |
| 2019-07-31 | $3.55M 10-Q · filed 2020-09-14 | |
| 2019-05-01 | $3.71M 10-K · filed 2020-07-28 | |
| 2019-04-30 | $0.00 10-Q · filed 2019-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |